Clinical Trials on Viremia

Total 211 results

University College, London

Completed

CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

Viraemia

United Kingdom
University Health Network, Toronto

Completed

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients (Q-CMV)

Cytomegalovirus Viraemia

Canada
University College, London

Completed

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Viraemia

United Kingdom
University Health Network, Toronto
Canadian National Transplant Research Program

Completed

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients (QFT-CMV)

Cytomegalovirus Viraemia

Spain, Canada
Changzheng-Cinkate

Terminated

An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria

Viremia | Viruria

United States
University of Athens

Unknown

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress (RECYSTRESS)

Stress, Physiological | Cytomegalovirus Viraemia | Receptor, Hormonal; Disorder | Other Deficiency of Cell-mediated Immunity

Greece
University of Minnesota

Completed

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

CMV Viremia | EBV Viremia

United States
Brigham and Women's Hospital

Completed

BK Treatment Study

BK Viremia

United States
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation (EBVALLO)

Hematologic Diseases | Allogeneic Disease | Epstein-Barr Viraemia

France
Hospital Israelita Albert Einstein

Recruiting

Expansion of Virus-Specific Lymphocytes for Cell Therapy

CMV | CMV Viremia

Brazil
University Medical Centre Ljubljana

Recruiting

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients (CYPHER-TXPilot)

CMV Viremia

Slovenia
Memo Therapeutics AG

Recruiting

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (SAFE KIDNEY II)

BK Viremia; BKV DNAemia

United States
University of Alabama at Birmingham

Completed

BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

BK Virus (BKV) Viremia

United States
University of Texas, El Paso
University of California, San Francisco; Centro de Integracion Juvenil; El Centro...

Active, not recruiting

Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression

HIV Viremia

Mexico
Banc de Sang i Teixits
Hospital Universitario La Fe; Vall d'Hebron Institute of Oncology

Completed

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

CMV Viremia | Immunosuppression-related Infectious Disease

Spain
Peking University People's Hospital

Unknown

The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human

Acute Leukemia | Hematopoietic Stem Cell Transplantation | CMV Viremia

China
Hospital do Rim e Hipertensão

Enrolling by invitation

Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil

CMV Infection | CMV Viremia

Brazil
Atara Biotherapeutics

No longer available

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

CMV Viremia | CMV Disease
Columbia University
Pfizer; Cornell University

Completed

Using mTOR Inhibitors in the Prevention of BK Nephropathy

BK Viremia | BK Nephropathy

United States
University of Alabama at Birmingham

Recruiting

Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation (CMV)

Cmv Congenital | CMV Viremia

Brazil
Memorial Sloan Kettering Cancer Center

Recruiting

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

CMV Infection | Persistent CMV Viremia

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial (VRC 603)

HIV-1 Infected Adults With Controlled Viremia

United States
Brown University

Recruiting

Using Telehealth to Address Alcohol Misuse in HIV Care (ReACH3)

Alcohol Drinking | HIV Viremia

United States
Methodist Health System

Enrolling by invitation

Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant

Liver Transplant Infection | Kidney Transplant Infection | Polyomavirus Infections | BK Viremia

United States
University of Wisconsin, Madison
University of Wisconsin Carbone Cancer Center (UWCCC)

Recruiting

Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells

Cytomegalovirus Infections | Opportunistic Infections | CMV Infection | CMV Viremia

United States
Peking University People's Hospital

Recruiting

CMV Infection and Immune Intervention After Transplantation

Transplantation Infection | CMV Viremia

China
Foundation IRCCS San Matteo Hospital
Ministero della Salute, Italy

Recruiting

HCMV Breakthrough Infections During Letermovir Prophylaxis (CMVbreak)

Cytomegalovirus Infections | Hematopoietic Stem Cell Transplantation | Cytomegalovirus Viremia

Italy
Gruppo Italiano Trapianto di Midollo Osseo
Azienda Policlinico Umberto I

Completed

Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT (CYTOALLOSURVEY)

Hematologic Diseases | Stem Cell Transplant Complications | Cytomegalovirus Viremia | Herpesvirus Infection

Italy
The University of Queensland

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients (BEAT-BK)

Kidney Transplant Infection | Kidney Transplant Failure and Rejection | BK Viremia

Australia
Vera Therapeutics, Inc.

Completed

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

BK Virus Infection

United States, Canada
Chimerix

Completed

CMX001 in Post-transplant Patients With BK Virus Viruria

Viruria

United States
St Stephens Aids Trust

Unknown

Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy

HIV

United Kingdom
University of Guelph

Completed

Emulsion Droplet Physical State on Postprandial Lipemia and Satiety

Satiety | Postprandial Lipemia

Canada
Germans Trias i Pujol Hospital

Completed

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

HIV

Spain
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia

HIV

Spain
University of Minnesota

Withdrawn

Predictors of Time to Viremia With an Analytic Treatment Interruption

HIV

United States
University of Zurich
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Role of Biomarkers in Patients Undergoing Dialysis Treatment (DRYWEIGHT)

Volemia in Dialysis Patients

Switzerland
Malaysia Palm Oil Board
National University of Malaysia; Taylor's University

Recruiting

Exploring the Effects of Varying Fat:Carbohydrate Diet Permutations on Gastric Emptying and Metabolic Status Using Human Postprandial Model

Gastric Emptying | Postprandial Lipemia | Postprandial Glycemia

Malaysia
University of Sao Paulo General Hospital

Not yet recruiting

Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals

HIV Vaccine

Brazil
Massachusetts General Hospital

Completed

IVIg to Treat BK Viremia in Kidney Transplant Recipients

Kidney Transplantation | BK Virus | Isoantibodies

United States
University of Pittsburgh
National Cancer Institute (NCI)

Completed

Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia

HIV Infection

United States
University Hospital, Essen
Janssen Medical Affairs

Unknown

Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens

HIV-infection

Germany
National Taiwan Sport University

Completed

The Effect of Different Methods for Modulating Postprandial Fat Oxidation on Postprandial Lipemia the Next Day

Postprandial Lipemia | Time-restricted Feeding

Taiwan
Chimerix

Withdrawn

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

Adenovirus

United States, Spain, Italy
Atara Biotherapeutics
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Completed

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

EBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma

United States
ANRS, Emerging Infectious Diseases
Janssen-Cilag Ltd.

Terminated

Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

Viremia | HIV-1 Infection | Treatment Resistant Disorders

France
University of Aarhus
Aarhus University Hospital

Completed

Early Detection of Epstein-Barr Virus Related Disease.

Epstein-Barr Virus Infections | Post-transplant Lymphoproliferative Disorder | Hemophagocytic Lymphohistiocytoses | Epstein-Barr Virus-Related Hodgkin Lymphoma | Epstein-Barr Virus-Related Non-Hodgkin Lymphoma | Mononucleosis | Epstein-Barr Virus Related Malignancy | Epstein-Barr Viraemia | Hemophag...

Denmark
Salem Anaesthesia Pain Clinic

Recruiting

Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise

Steroid Metabolism Disorder

Canada
University of Florida
Novartis Pharmaceuticals

Completed

Induction Related BK Viremia in Renal Transplant Patients (BK)

Transplantation Infection | Disease Due to BK Polyomavirus | Disorder Related to Transplantation

United States
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response

Discordant Immunological Response in HIV Infected Subjects

Spain

Clinical Trials on Viremia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations